世界のSARS-CoV-2 IgG(RBD) ELISA市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global SARS-CoV-2 IgG(RBD) ELISA Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6004 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、SARS-CoV-2 IgG(RBD) ELISAの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ELISAセット、ELISAキット）、用途別市場規模（病院、クリニック、疾病管理予防システム）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・SARS-CoV-2 IgG(RBD) ELISAの市場動向 ・企業の競争状況、市場シェア ・SARS-CoV-2 IgG(RBD) ELISAの種類別市場規模と予測2016-2027（ELISAセット、ELISAキット） ・SARS-CoV-2 IgG(RBD) ELISAの用途別市場規模と予測2016-2027（病院、クリニック、疾病管理予防システム） ・SARS-CoV-2 IgG(RBD) ELISAの北米市場規模2016-2027（アメリカ、カナダ） ・SARS-CoV-2 IgG(RBD) ELISAの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・SARS-CoV-2 IgG(RBD) ELISAのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・SARS-CoV-2 IgG(RBD) ELISAの中南米市場規模2016-2027（メキシコ、ブラジル） ・SARS-CoV-2 IgG(RBD) ELISAの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（R&D Systems、Thermo Fisher Scientific、Ortho Clinical Diagnostics、BD Biosciences、ZEUS Scientific、Bio-Rad Laboratories、ALPCO、Enzo Life Sciences、BioMérieux、LOEWE Biochemica、Shenzhen YHLO Biotech、LG） ・結論

Market Analysis and Insights: Global SARS-CoV-2 IgG(RBD) ELISA Market
The global SARS-CoV-2 IgG(RBD) ELISA market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global SARS-CoV-2 IgG(RBD) ELISA market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global SARS-CoV-2 IgG(RBD) ELISA market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global SARS-CoV-2 IgG(RBD) ELISA market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global SARS-CoV-2 IgG(RBD) ELISA market.

Global SARS-CoV-2 IgG(RBD) ELISA Scope and Market Size
SARS-CoV-2 IgG(RBD) ELISA market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global SARS-CoV-2 IgG(RBD) ELISA market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
ELISA Sets
ELISA Kits

Segment by Application
Hospital
Clinic
Disease control and prevention system

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
LOEWE Biochemica
Shenzhen YHLO Biotech
LG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ELISA Sets
1.2.3 ELISA Kits
1.3 Market by Application
1.3.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Disease control and prevention system
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Perspective (2016-2027)
2.2 SARS-CoV-2 IgG(RBD) ELISA Growth Trends by Regions
2.2.1 SARS-CoV-2 IgG(RBD) ELISA Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 SARS-CoV-2 IgG(RBD) ELISA Historic Market Share by Regions (2016-2021)
2.2.3 SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Regions (2022-2027)
2.3 SARS-CoV-2 IgG(RBD) ELISA Industry Dynamic
2.3.1 SARS-CoV-2 IgG(RBD) ELISA Market Trends
2.3.2 SARS-CoV-2 IgG(RBD) ELISA Market Drivers
2.3.3 SARS-CoV-2 IgG(RBD) ELISA Market Challenges
2.3.4 SARS-CoV-2 IgG(RBD) ELISA Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top SARS-CoV-2 IgG(RBD) ELISA Players by Revenue
3.1.1 Global Top SARS-CoV-2 IgG(RBD) ELISA Players by Revenue (2016-2021)
3.1.2 Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Players (2016-2021)
3.2 Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by SARS-CoV-2 IgG(RBD) ELISA Revenue
3.4 Global SARS-CoV-2 IgG(RBD) ELISA Market Concentration Ratio
3.4.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by SARS-CoV-2 IgG(RBD) ELISA Revenue in 2020
3.5 SARS-CoV-2 IgG(RBD) ELISA Key Players Head office and Area Served
3.6 Key Players SARS-CoV-2 IgG(RBD) ELISA Product Solution and Service
3.7 Date of Enter into SARS-CoV-2 IgG(RBD) ELISA Market
3.8 Mergers & Acquisitions, Expansion Plans

4 SARS-CoV-2 IgG(RBD) ELISA Breakdown Data by Type
4.1 Global SARS-CoV-2 IgG(RBD) ELISA Historic Market Size by Type (2016-2021)
4.2 Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Type (2022-2027)

5 SARS-CoV-2 IgG(RBD) ELISA Breakdown Data by Application
5.1 Global SARS-CoV-2 IgG(RBD) ELISA Historic Market Size by Application (2016-2021)
5.2 Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
6.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
6.2.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
6.2.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
6.2.3 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
6.3 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
6.3.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
6.3.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
6.3.3 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
6.4 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
6.4.1 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
6.4.2 North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
7.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
7.2.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
7.2.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
7.2.3 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
7.3 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
7.3.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
7.3.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
7.3.3 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
7.4 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
7.4.1 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
7.4.2 Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
8.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
8.2.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
8.2.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
8.2.3 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
8.3 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
8.3.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
8.3.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
8.3.3 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
8.4 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region
8.4.1 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region (2016-2021)
8.4.2 Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
9.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
9.2.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
9.2.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
9.2.3 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
9.3 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
9.3.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
9.3.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
9.3.3 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
9.4 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
9.4.1 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
9.4.2 Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size (2016-2027)
10.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type
10.2.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021)
10.2.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027)
10.2.3 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2027)
10.3 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application
10.3.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021)
10.3.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027)
10.3.3 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2027)
10.4 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country
10.4.1 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021)
10.4.2 Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 R&D Systems
11.1.1 R&D Systems Company Details
11.1.2 R&D Systems Business Overview
11.1.3 R&D Systems SARS-CoV-2 IgG(RBD) ELISA Introduction
11.1.4 R&D Systems Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.1.5 R&D Systems Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG(RBD) ELISA Introduction
11.2.4 Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Ortho Clinical Diagnostics
11.3.1 Ortho Clinical Diagnostics Company Details
11.3.2 Ortho Clinical Diagnostics Business Overview
11.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG(RBD) ELISA Introduction
11.3.4 Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.3.5 Ortho Clinical Diagnostics Recent Development
11.4 BD Biosciences
11.4.1 BD Biosciences Company Details
11.4.2 BD Biosciences Business Overview
11.4.3 BD Biosciences SARS-CoV-2 IgG(RBD) ELISA Introduction
11.4.4 BD Biosciences Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.4.5 BD Biosciences Recent Development
11.5 ZEUS Scientific
11.5.1 ZEUS Scientific Company Details
11.5.2 ZEUS Scientific Business Overview
11.5.3 ZEUS Scientific SARS-CoV-2 IgG(RBD) ELISA Introduction
11.5.4 ZEUS Scientific Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.5.5 ZEUS Scientific Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG(RBD) ELISA Introduction
11.6.4 Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 ALPCO
11.7.1 ALPCO Company Details
11.7.2 ALPCO Business Overview
11.7.3 ALPCO SARS-CoV-2 IgG(RBD) ELISA Introduction
11.7.4 ALPCO Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.7.5 ALPCO Recent Development
11.8 Enzo Life Sciences
11.8.1 Enzo Life Sciences Company Details
11.8.2 Enzo Life Sciences Business Overview
11.8.3 Enzo Life Sciences SARS-CoV-2 IgG(RBD) ELISA Introduction
11.8.4 Enzo Life Sciences Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.8.5 Enzo Life Sciences Recent Development
11.9 BioMérieux
11.9.1 BioMérieux Company Details
11.9.2 BioMérieux Business Overview
11.9.3 BioMérieux SARS-CoV-2 IgG(RBD) ELISA Introduction
11.9.4 BioMérieux Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.9.5 BioMérieux Recent Development
11.10 LOEWE Biochemica
11.10.1 LOEWE Biochemica Company Details
11.10.2 LOEWE Biochemica Business Overview
11.10.3 LOEWE Biochemica SARS-CoV-2 IgG(RBD) ELISA Introduction
11.10.4 LOEWE Biochemica Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.10.5 LOEWE Biochemica Recent Development
11.11 Shenzhen YHLO Biotech
11.11.1 Shenzhen YHLO Biotech Company Details
11.11.2 Shenzhen YHLO Biotech Business Overview
11.11.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG(RBD) ELISA Introduction
11.11.4 Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.11.5 Shenzhen YHLO Biotech Recent Development
11.12 LG
11.12.1 LG Company Details
11.12.2 LG Business Overview
11.12.3 LG SARS-CoV-2 IgG(RBD) ELISA Introduction
11.12.4 LG Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
11.12.5 LG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global SARS-CoV-2 IgG(RBD) ELISA Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ELISA Sets
Table 3. Key Players of ELISA Kits
Table 4. Global SARS-CoV-2 IgG(RBD) ELISA Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global SARS-CoV-2 IgG(RBD) ELISA Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global SARS-CoV-2 IgG(RBD) ELISA Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Regions (2016-2021)
Table 8. Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Regions (2022-2027)
Table 10. SARS-CoV-2 IgG(RBD) ELISA Market Trends
Table 11. SARS-CoV-2 IgG(RBD) ELISA Market Drivers
Table 12. SARS-CoV-2 IgG(RBD) ELISA Market Challenges
Table 13. SARS-CoV-2 IgG(RBD) ELISA Market Restraints
Table 14. Global SARS-CoV-2 IgG(RBD) ELISA Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Players (2016-2021)
Table 16. Global Top SARS-CoV-2 IgG(RBD) ELISA Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SARS-CoV-2 IgG(RBD) ELISA as of 2020)
Table 17. Ranking of Global Top SARS-CoV-2 IgG(RBD) ELISA Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by SARS-CoV-2 IgG(RBD) ELISA Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players SARS-CoV-2 IgG(RBD) ELISA Product Solution and Service
Table 21. Date of Enter into SARS-CoV-2 IgG(RBD) ELISA Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 24. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Type (2016-2021)
Table 25. Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global SARS-CoV-2 IgG(RBD) ELISA Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Application (2016-2021)
Table 29. Global SARS-CoV-2 IgG(RBD) ELISA Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 32. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021) (US$ Million)
Table 34. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size by Country (2022-2027) & (US$ Million)
Table 61. R&D Systems Company Details
Table 62. R&D Systems Business Overview
Table 63. R&D Systems SARS-CoV-2 IgG(RBD) ELISA Product
Table 64. R&D Systems Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 65. R&D Systems Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific SARS-CoV-2 IgG(RBD) ELISA Product
Table 69. Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Ortho Clinical Diagnostics Company Details
Table 72. Ortho Clinical Diagnostics Business Overview
Table 73. Ortho Clinical Diagnostics SARS-CoV-2 IgG(RBD) ELISA Product
Table 74. Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 75. Ortho Clinical Diagnostics Recent Development
Table 76. BD Biosciences Company Details
Table 77. BD Biosciences Business Overview
Table 78. BD Biosciences SARS-CoV-2 IgG(RBD) ELISA Product
Table 79. BD Biosciences Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 80. BD Biosciences Recent Development
Table 81. ZEUS Scientific Company Details
Table 82. ZEUS Scientific Business Overview
Table 83. ZEUS Scientific SARS-CoV-2 IgG(RBD) ELISA Product
Table 84. ZEUS Scientific Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 85. ZEUS Scientific Recent Development
Table 86. Bio-Rad Laboratories Company Details
Table 87. Bio-Rad Laboratories Business Overview
Table 88. Bio-Rad Laboratories SARS-CoV-2 IgG(RBD) ELISA Product
Table 89. Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 90. Bio-Rad Laboratories Recent Development
Table 91. ALPCO Company Details
Table 92. ALPCO Business Overview
Table 93. ALPCO SARS-CoV-2 IgG(RBD) ELISA Product
Table 94. ALPCO Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 95. ALPCO Recent Development
Table 96. Enzo Life Sciences Company Details
Table 97. Enzo Life Sciences Business Overview
Table 98. Enzo Life Sciences Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 99. Enzo Life Sciences Recent Development
Table 100. BioMérieux Company Details
Table 101. BioMérieux Business Overview
Table 102. BioMérieux SARS-CoV-2 IgG(RBD) ELISA Product
Table 103. BioMérieux Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 104. BioMérieux Recent Development
Table 105. LOEWE Biochemica Company Details
Table 106. LOEWE Biochemica Business Overview
Table 107. LOEWE Biochemica SARS-CoV-2 IgG(RBD) ELISA Product
Table 108. LOEWE Biochemica Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 109. LOEWE Biochemica Recent Development
Table 110. Shenzhen YHLO Biotech Company Details
Table 111. Shenzhen YHLO Biotech Business Overview
Table 112. Shenzhen YHLO Biotech SARS-CoV-2 IgG(RBD) ELISA Product
Table 113. Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 114. Shenzhen YHLO Biotech Recent Development
Table 115. LG Company Details
Table 116. LG Business Overview
Table 117. LG SARS-CoV-2 IgG(RBD) ELISA Product
Table 118. LG Revenue in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021) & (US$ Million)
Table 119. LG Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Type: 2020 VS 2027
Figure 2. ELISA Sets Features
Figure 3. ELISA Kits Features
Figure 4. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Disease control and prevention system Case Studies
Figure 8. SARS-CoV-2 IgG(RBD) ELISA Report Years Considered
Figure 9. Global SARS-CoV-2 IgG(RBD) ELISA Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global SARS-CoV-2 IgG(RBD) ELISA Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Regions: 2020 VS 2027
Figure 12. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Regions (2022-2027)
Figure 13. Global SARS-CoV-2 IgG(RBD) ELISA Market Share by Players in 2020
Figure 14. Global Top SARS-CoV-2 IgG(RBD) ELISA Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SARS-CoV-2 IgG(RBD) ELISA as of 2020
Figure 15. The Top 10 and 5 Players Market Share by SARS-CoV-2 IgG(RBD) ELISA Revenue in 2020
Figure 16. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Type (2016-2021)
Figure 17. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share by Type (2022-2027)
Figure 18. North America SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America SARS-CoV-2 IgG(RBD) ELISA Market Share by Type (2016-2027)
Figure 20. North America SARS-CoV-2 IgG(RBD) ELISA Market Share by Application (2016-2027)
Figure 21. North America SARS-CoV-2 IgG(RBD) ELISA Market Share by Country (2016-2027)
Figure 22. United States SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe SARS-CoV-2 IgG(RBD) ELISA Market Share by Type (2016-2027)
Figure 26. Europe SARS-CoV-2 IgG(RBD) ELISA Market Share by Application (2016-2027)
Figure 27. Europe SARS-CoV-2 IgG(RBD) ELISA Market Share by Country (2016-2027)
Figure 28. Germany SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Share by Type (2016-2027)
Figure 36. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Share by Application (2016-2027)
Figure 37. Asia-Pacific SARS-CoV-2 IgG(RBD) ELISA Market Share by Region (2016-2027)
Figure 38. China SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Share by Type (2016-2027)
Figure 46. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Share by Application (2016-2027)
Figure 47. Latin America SARS-CoV-2 IgG(RBD) ELISA Market Share by Country (2016-2027)
Figure 48. Mexico SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Share by Type (2016-2027)
Figure 52. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Share by Application (2016-2027)
Figure 53. Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Market Share by Country (2016-2027)
Figure 54. Turkey SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE SARS-CoV-2 IgG(RBD) ELISA Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. R&D Systems Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 59. Ortho Clinical Diagnostics Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 60. BD Biosciences Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 61. ZEUS Scientific Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 62. Bio-Rad Laboratories Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 63. ALPCO Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 64. Enzo Life Sciences Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 65. BioMérieux Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 66. LOEWE Biochemica Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 67. Shenzhen YHLO Biotech Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 68. LG Revenue Growth Rate in SARS-CoV-2 IgG(RBD) ELISA Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---